I think you are a bit impatient, twigman. It is only two weeks...

I think you are a bit impatient, twigman. It is only two weeks since the results in Nadolol were released. It is only at this time that these results would have gone out to interested companies. You have to realise that these are mostly huge bureaucracies. The results go firstly to some rather junior person along with a heap of other incoming emails. If the Invion message takes his eye, he will commence a report to his superiors, or if we are lucky to a committee which meets fortnightly or monthly to consider acquisitions, investments, partnerships, etc. There will be cost/reward analysis and a heap of reports. Only then will the matter be considered by anyone with authority. At that stage the best we can hope for is a decision to enter into a confidentiality agreement and the start of due diligence. Cpn10 results have been released a couple of months ago, and we could possibly be at the beginning of negotiations there. Nadolol will be at least a couple of months before negotiations even start. If we hear anything this calendar year we will be very lucky. These things do not move more quickly than that. The 0nly possibility of something before then, in MHO, will be if Pfizer panic and decide that they cannot let anyone else get to Nadolol before them. That is a low probability.